Cytological specimens' relative contribution in establishing histological diagnosis of lung cancer

S. Michaelides, A. Emmanouelidou, G. Bablekos, G. Ionas, H. Ellina, N. Maouni, I. Platanos (Athens, Greece)

Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Session: Diagnosis, imaging and surgery for thoracic tumours
Session type: Thematic Poster Session
Number: 2768
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Michaelides, A. Emmanouelidou, G. Bablekos, G. Ionas, H. Ellina, N. Maouni, I. Platanos (Athens, Greece). Cytological specimens' relative contribution in establishing histological diagnosis of lung cancer. Eur Respir J 2014; 44: Suppl. 58, 2768

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchoscopic semantics and diagnosis of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013


Added value of EUS-B to EBUS for lung cancer staging
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015

Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015


Subtyping agreement between small cyto-histological samples and surgical specimens in NSCLC patients
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Determinants of negative predictive value during EBUS-TBNA in diagnosis/staging of lung cancer
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Lung cancer revisited – CT scan and bronchoscopy concordance after treatment
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Bronchoscopic dissection
Source: International Congress 2015 – Advances in therapeutic bronchoscopy
Year: 2015


Role of the EBUS-EUS-FNA combined approach by using single ultrasound bronchoscope for tissue diagnosis in mediastinal lymphadenopathy
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Variation in lung cancer diagnosis in England
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013

Systematic vs hit-and-run endosonographic staging of lung cancer
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014

Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging
Source: Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond
Year: 2013


Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results?
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016


Electrospray-mediated local chemotherapy of lung carcinoma in mice
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

EBUS in real life: Primary diagnosis and mediastinal staging
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis?
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


EBUS-TBNA for nodal restaging and relapse in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013



Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first?
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014